iBio (IBIO) FCF Margin Growth (1y) (2012 - 2025)
iBio (IBIO) FCF Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 59,321.00 |
| Mar 31, 2022 | 72,446.00 |
| Sep 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | -156,639.00 |
| Mar 31, 2021 | 292,517.00 |
| Dec 31, 2020 | -18,645.00 |
| Sep 30, 2020 | 29,101.00 |
| Jun 30, 2020 | 15,324.00 |
| Mar 31, 2020 | -320,671.00 |
| Dec 31, 2019 | -37,392.00 |
| Sep 30, 2019 | 22,019.00 |
| Jun 30, 2019 | 338,218.00 |
| Mar 31, 2019 | 423,595.00 |
| Dec 31, 2018 | 168,859.00 |
| Sep 30, 2018 | 21,386.00 |
| Jun 30, 2018 | -104,186.00 |
| Mar 31, 2018 | 530,918.00 |
| Dec 31, 2017 | 247,393.00 |
| Sep 30, 2017 | -57,164.00 |
| Jun 30, 2017 | -186,288.00 |